INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 32 filers reported holding INMUNE BIO INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $314,565 | +53.0% | 45,989 | +103.1% | 0.00% | 0.0% |
| Q2 2023 | $205,553 | +252.1% | 22,638 | +150.5% | 0.00% | – |
| Q1 2023 | $58,373 | +601.8% | 9,036 | +588.7% | 0.00% | – |
| Q4 2022 | $8,318 | -96.3% | 1,312 | -96.4% | 0.00% | – |
| Q3 2022 | $224,000 | -24.3% | 36,156 | +8.0% | 0.00% | – |
| Q2 2022 | $296,000 | +46.5% | 33,473 | +39.7% | 0.00% | – |
| Q1 2022 | $202,000 | -35.7% | 23,954 | -22.3% | 0.00% | – |
| Q4 2021 | $314,000 | -9.2% | 30,827 | +73.1% | 0.00% | – |
| Q3 2021 | $346,000 | +322.0% | 17,806 | +280.8% | 0.00% | – |
| Q2 2021 | $82,000 | – | 4,676 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 275,000 | $5,341,000 | 2.77% |
| Fermata Advisors, LLC | 12,830 | $249,000 | 0.11% |
| DG Capital Management, LLC | 20,000 | $388,000 | 0.08% |
| YorkBridge Wealth Partners, LLC | 10,369 | $201,000 | 0.05% |
| Ikarian Capital, LLC | 26,632 | $517,000 | 0.04% |
| Financial Advocates Investment Management | 16,667 | $324,000 | 0.02% |
| Janney Montgomery Scott LLC | 99,323 | $1,929,000 | 0.01% |
| Belvedere Trading LLC | 16,177 | $302,000 | 0.01% |
| FNY Investment Advisers, LLC | 800 | $15,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 17,200 | $334,000 | 0.01% |